Literature DB >> 34318428

MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.

L F Gao1, S Jia2, Q M Zhang3, Y F Xia4, C J Li4, Y H Li5.   

Abstract

PURPOSE: Increasing evidences suggest dysfunctions of microRNAs (miRNAs) are playing important part in tumors. Therefore, the role of miR-802 in osteosarcoma (OS) was exploited. The object was to evaluate the effect of miR-802 and verify its influence on p27 Kip1 (p27) in OS.
METHODS: RT-qPCR experiment was used to detect miR-802 and p27 expression in OS tissues and cells. We explored the function of miR-802 through Transwell assays. The phosphoinositide 3-kinase (PI3K)/AKT serine/threonine kinase pathway and epithelial-mesenchymal transition (EMT) was detected by Western blot assays. Luciferase assay was used to testify the target of miR-802.
RESULTS: MiR-802 expression was elevated in OS, which was related to poor clinical outcome in OS patients. MiR-802 overexpression promoted OS migration, invasion and EMT. Further, p27 is a direct target of miR-802. P27 elevation counteracted the promotion effect of OS on EMT, migration and invasion induced by miR-802. In addition, miR-802 overexpression inactivated PI3K/AKT pathway via targeting p27 in OS.
CONCLUSION: MiR-802 promoted the progress of EMT, migration and invasion in OS via targeting p27. This newly identified miR-802/p27/PI3K/AKT axis may represent potential targets for OS.
© 2021. Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Invasion; MiR-802; Migration; Osteosarcoma; p27

Mesh:

Substances:

Year:  2021        PMID: 34318428     DOI: 10.1007/s12094-021-02683-w

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  6 in total

Review 1.  Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Biochim Biophys Acta       Date:  2011-11-03

2.  microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting HMGA1 and deactivating the Wnt/β-catenin pathway.

Authors:  Jia Ren; Mengjie Yang; Fengyang Xu; Juwu Chen
Journal:  Am J Cancer Res       Date:  2019-01-01       Impact factor: 6.166

3.  MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27.

Authors:  Zhong-Qing Cao; Zan Shen; Wei-Yi Huang
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.

Authors:  X-Y Zhang; J-H Mu; L-Y Liu; H-Z Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-09       Impact factor: 3.507

5.  MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27Kip1.

Authors:  Yangyang Wang; Jiping Zeng; Jianyong Pan; Xue Geng; Yansong Liu; Jing Wu; Ping Song; Ying Wang; Jihui Jia; Lixiang Wang
Journal:  Biochem Biophys Rep       Date:  2016-09-19

6.  Epidemiology and therapies for metastatic sarcoma.

Authors:  Ernest K Amankwah; Anthony P Conley; Damon R Reed
Journal:  Clin Epidemiol       Date:  2013-05-16       Impact factor: 4.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.